Hajar Ashrafi
- Biomaterials top 5%
- Pharmaceutical Science top 1%
- Molecular Biology
- Biomedical Engineering
- Molecular Medicine top 5%
- Co-authors
- Amir AzadiLeila Pourtalebi JahromiNegin MozafariPedram RafieiMehrdad HamidiSoliman Mohammadi‐SamaniReza HeidariRamin Ansari
- Topics
- Advanced Drug Delivery Systems (12 papers)Nanoparticle-Based Drug Delivery (8 papers)Advancements in Transdermal Drug Delivery (5 papers)
- Journals
- SHILAP Revista de lepidopterologíaInternational Journal of PharmaceuticsJournal of Ethnopharmacology
- Partner nations
- IranNetherlandsCanada
In The Last Decade
Hajar Ashrafi
35 papers receiving 790 citations
Peers
Comparison fields: 5 of 106
- Biomaterials 280
- Pharmaceutical Science 265
- Molecular Biology 187
- Biomedical Engineering 140
- Molecular Medicine 79
Countries citing papers authored by Hajar Ashrafi
This map shows the geographic impact of Hajar Ashrafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajar Ashrafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajar Ashrafi more than expected).
Fields of papers citing papers by Hajar Ashrafi
This network shows the impact of papers produced by Hajar Ashrafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajar Ashrafi. The network helps show where Hajar Ashrafi may publish in the future.
Co-authorship network of co-authors of Hajar Ashrafi
This figure shows the co-authorship network connecting the top 25 collaborators of Hajar Ashrafi. A scholar is included among the top collaborators of Hajar Ashrafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajar Ashrafi. Hajar Ashrafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 36 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 12 | |
| 8 | 30 | |
| 9 | 18 | |
| 10 | 6 | |
| 11 | 48 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 14 | |
| 15 | 22 | |
| 16 | 2 | |
| 17 | 4 | |
| 18 | 2 | |
| 19 | 31 | |
| 20 | Drug abuse in sport : doping | 0 |
About Hajar Ashrafi
Hajar Ashrafi is a scholar working on Pharmaceutical Science, Biological Psychiatry and Biomaterials, having authored 40 papers that have together received 803 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (12 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advancements in Transdermal Drug Delivery (5 papers). The work is most often cited by research in Pharmaceutical Science (265 citations), Biomaterials (280 citations) and Molecular Medicine (79 citations). Hajar Ashrafi has collaborated with scholars based in Iran, Netherlands and Canada. Frequent co-authors include Amir Azadi, Leila Pourtalebi Jahromi, Negin Mozafari, Pedram Rafiei, Mehrdad Hamidi, Soliman Mohammadi‐Samani, Reza Heidari, Ramin Ansari, Saeid Daneshamouz and Mohammad‐Ali Shahbazi. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.